Nakanishi (7716) Acquisition presentation summary
Event summary combining transcript, slides, and related documents.
Acquisition presentation summary
16 Mar, 2026M&A structure
Acquired 100% of Acra Cut (100 shares) and Intech (1,075 shares) through NSK America using borrowings and cash on hand.
Board resolution and contract executed on March 5, 2026; share transfer planned for April 1, 2026.
Post-merger integration led by Nakanishi and NSK America's Surgical Division.
Overview of Acra Cut and Intech
Acra Cut, based in Acton, MA, develops and sells neurosurgical medical devices, notably cranial perforators; established in 1982 with 12 employees.
Intech, also in Acton, MA, manufactures precision components used in Acra Cut products; established in 1966 with 21 employees.
Market environment and positioning
Global cranial perforator market estimated at $120–150M, with 2–5% CAGR; U.S. is the largest market (40%).
Acra Cut and Intech hold high market share in the U.S. and Japan, recognized for quality and strong brand.
Limited presence in Europe and Asia due to aggressive low-price competitors.
Latest events from Nakanishi
- Net sales up 5.4% YoY, but DCI impairment led to a net loss; record sales and profit forecast for FY2026.7716
Q4 202512 Feb 2026 - Net sales up 3.8% YoY, but EBITDA and net income declined; guidance unchanged.7716
Q3 20256 Nov 2025 - Surgical growth offset flat sales, but net income dropped 50% amid currency headwinds.7716
Q2 20258 Aug 2025 - Sales surged 37.4% but net profit dropped 63.7%; outlook and dividend steady.7716
Q3 202413 Jun 2025 - Sales surged 36.4% year-over-year, but net income declined 11.9% amid mixed segment results.7716
Q2 202413 Jun 2025 - Sales rose, but profits plunged on forex and tax hits; outlook lowered amid global risks.7716
Q1 20256 Jun 2025 - Record sales, sharp profit drop; FY2025 sees higher dividend and cautious outlook.7716
Q4 20245 Jun 2025